An	DT
inhibitor	NN
of	IN
NADPH	NN
oxidase-4	NN
attenuates	VBZ
established	JJ
pulmonary	JJ
fibrosis	NN
in	IN
a	DT
rodent	JJ
disease	NN
model	NN
.	.

Idiopathic	JJ
pulmonary	JJ
fibrosis	NN
is	VBZ
a	DT
chronic	JJ
progressive	JJ
disease	NN
of	IN
increasing	VBG
prevalence	NN
for	IN
which	WDT
there	EX
is	VBZ
no	DT
effective	JJ
therapy	NN
.	.

Increased	VBN
oxidative	JJ
stress	NN
associated	VBN
with	IN
an	DT
oxidant-antioxidant	JJ
imbalance	NN
is	VBZ
thought	VBN
to	TO
contribute	VB
to	TO
disease	NN
progression	NN
.	.

NADPH	NN
oxidases	NNS
(	(
Nox	NN
)	)
are	VBP
a	DT
primary	JJ
source	NN
of	IN
reactive	JJ
oxygen	NN
species	NNS
within	IN
the	DT
lung	NN
and	CC
cardiovascular	JJ
system	NN
.	.

We	PRP
demonstrate	VBP
that	IN
the	DT
Nox4	NN
isoform	NN
is	VBZ
up-regulated	VBN
in	IN
the	DT
lungs	NNS
of	IN
patients	NNS
with	IN
IPF	NN
and	CC
in	IN
a	DT
rodent	JJ
model	NN
of	IN
bleomycin-induced	JJ
pulmonary	JJ
fibrosis	NN
and	CC
vascular	JJ
remodeling	NN
.	.

Nox4	NN
is	VBZ
constitutively	RB
active	JJ
,	,
and	CC
therefore	RB
increased	VBN
expression	NN
levels	NNS
are	VBP
likely	JJ
to	TO
contribute	VB
to	TO
disease	NN
pathology	NN
.	.

Using	VBG
a	DT
small	JJ
molecule	NN
Nox4/Nox1	NN
inhibitor	NN
,	,
we	PRP
demonstrate	VBP
that	IN
targeting	VBG
Nox4	JJ
results	NNS
in	IN
attenuation	NN
of	IN
an	DT
established	JJ
fibrotic	JJ
response	NN
,	,
with	IN
reductions	NNS
in	IN
gene	NN
transcripts	NNS
for	IN
the	DT
extracellular	JJ
matrix	NN
components	NNS
collagen	NN
1a1	NN
,	,
collagen	NN
3a1	NN
,	,
and	CC
fibronectin	NN
and	CC
in	IN
principle	NN
pathway	NN
components	NNS
associated	VBN
with	IN
pulmonary	JJ
fibrosis	NN
and	CC
hypoxia-mediated	JJ
vascular	JJ
remodeling	NN
:	:
transforming	VBG
growth	NN
factor	NN
(	(
TGF	NN
)	)
-	:
b1	NN
,	,
plasminogen-activator-inhibitor-1	NN
,	,
hypoxia-inducible	JJ
factor	NN
,	,
and	CC
Nox4	NN
.	.

TGF-b1	NN
is	VBZ
a	DT
principle	NN
fibrotic	JJ
mediator	NN
responsible	JJ
for	IN
inducing	VBG
up-regulation	NN
of	IN
profibrotic	JJ
pathways	NNS
associated	VBN
with	IN
disease	NN
pathology	NN
.	.

Using	VBG
normal	JJ
human	JJ
lung-derived	JJ
primary	JJ
fibroblasts	NNS
,	,
we	PRP
demonstrate	VBP
that	IN
inhibition	NN
of	IN
Nox4	NN
activity	NN
using	VBG
a	DT
small	JJ
molecule	NN
antagonist	NN
attenuates	VBZ
TGF-b1-mediated	JJ
up-regulation	NN
in	IN
expression	NN
of	IN
profibrotic	JJ
genes	NNS
and	CC
inhibits	VBZ
the	DT
differentiation	NN
of	IN
fibroblast	NN
to	TO
myofibroblasts	NNS
,	,
that	DT
is	VBZ
associated	VBN
with	IN
up-regulation	NN
in	IN
smooth	JJ
muscle	NN
actin	NN
and	CC
acquisition	NN
of	IN
a	DT
contractile	JJ
phenotype	NN
.	.

These	DT
studies	NNS
support	VBP
the	DT
view	NN
that	IN
targeting	VBG
Nox4	NN
may	MD
provide	VB
a	DT
therapeutic	JJ
approach	NN
for	IN
attenuating	VBG
pulmonary	JJ
fibrosis	NN
.	.

